Non-Invasive Embryo Assessment: miR-375-3p and Live Birth

Non-invasive embryo assessment may draw clues from microRNAs in spent culture medium. A single-center study of 67 transferred embryos linked exosomal miR-375-3p with live birth and tested its role in mouse development. These early results identify a candidate marker, not a validated replacement for embryo grading or genetic testing.

Profiling exosomal microRNA (miRNA) in spent culture medium (SCM): hsa-miR-375-3p significantly elevated in culture droplets of embryos resulting in live birth
Diagnostic performance: AUC = 0.763, sensitivity 85%, specificity 70%—demonstrating the potential for non-invasive embryo assessment without mechanical biopsy
Functional mouse assays confirm active biological role: suppressing miR-375-3p significantly impaired embryonic progression at the 4-to-8 cell cleavage stage
Single-center pilot study (n = 67): Serves as a potential complementary biomarker for developmental competence, not an immediate replacement for PGT-A

Embryo selection in In Vitro Fertilization (IVF) is expanding beyond “inspecting the embryo itself” to “decoding the molecular footprints it leaves behind.”

A study published in Reproductive BioMedicine Online (RBMO) explored whether analyzing trace molecules within the droplets of fluid left after culturing human embryos can predict which embryo is most likely to result in a live birth.

The central candidate identified was a microRNA designated hsa-miR-375-3p. While this non-invasive methodology remains in early research stages and is not yet ready for routine clinical adoption, it represents a step toward evaluating an embryo’s developmental competence without the cellular stress of an invasive biopsy.

What spent culture medium can reveal about an embryo

Standard laboratory assessment of embryo quality relies primarily on high-resolution optical microscopy to grade cell symmetry, fragmentation, and blastocyst expansion. More recently, time-lapse imaging (TLI) paired with artificial intelligence (AI) algorithms has enabled continuous tracking of dynamic cell division intervals (morphokinetics).

Conversely, Preimplantation Genetic Testing for Aneuploidy (PGT-A) takes an invasive approach: using a laser to breach the protective zona pellucida and aspirating 5 to 10 cells from the trophectoderm (the precursor to the placenta) for chromosomal copy-number analysis.

This study evaluated an entirely non-invasive paradigm: spent culture medium (SCM) profiling.

Throughout in vitro culture, an embryo metabolizes nutrients and actively secretes signaling molecules, metabolites, and nucleic acids into the surrounding micro-droplet of culture medium. Rather than touching or biopsying the embryonic cells, researchers harvest the fluid left behind after the embryo is removed for transfer or cryopreservation, analyzing its molecular “secretome.”

Exosomal microRNAs and the live-birth association

The investigators focused their analysis specifically on embryonic exosomes isolated from the spent culture medium.

Exosomes are nanoscale extracellular vesicles (EVs) secreted by living cells that package functional biological cargo, including proteins, lipids, and non-coding regulatory RNAs. They function essentially as molecular messaging capsules operating between cells:

Small Non-Coding RNA Profiling: The researchers extracted exosomes from the droplet fluid and profiled their non-coding RNA composition, identifying 51 microRNAs (miRNAs), 547 PIWI-interacting RNAs (piRNAs), and 39 transfer RNA fragments (tRFs).
Biomarker Identification: Several molecules exhibited divergent expression profiles between embryos that achieved live birth and those that failed. Most notably, hsa-miR-375-3p (and miR-215-5p) were significantly enriched in the exosomes of embryos that progressed to successful delivery.
Predictive Performance: Receiver Operating Characteristic (ROC) curve analysis of miR-375-3p yielded an Area Under the Curve (AUC) of 0.763, with a sensitivity of 85% and a specificity of 70%.

An AUC of 0.763 indicates moderate-to-good discriminatory capability in distinguishing live-birth from non-live-birth outcomes. However, it also means miR-375-3p is an exploratory candidate biomarker rather than an absolute standalone diagnostic test.

Comparing embryo assessment methods and their limits

Evaluation Modality	Target Analyzed	Invasiveness	Primary Clinical Objective	Inherent Limitations
Standard Morphology	Visual shape, fragmentation, blastocyst expansion	Non-invasive	Baseline embryo grading	Subjective; poor correlation with chromosomal ploidy
Time-Lapse Imaging (AI)	Dynamic cleavage timing & division kinetics	Non-invasive	Ranking embryos by kinetic competence	High equipment cost; cannot identify chromosomal aneuploidy
Trophectoderm PGT-A	5–10 cells biopsied from trophectoderm	Invasive	Screening numerical chromosomal aneuploidy	Requires blastocyst biopsy; risk of cell damage; mosaicism ambiguity
Spent Medium Exosomal miRNA (Emerging)	Secreted exosomal cargo (`miR-375-3p`) in SCM	Non-invasive	Investigating RNA markers associated with live birth	Experimental; requires standardized isolation protocols & larger validation

What the mouse experiments show about early cleavage

The research team went beyond establishing a statistical correlation. To determine whether miR-375-3p plays an active biological role during early development, they conducted functional loss-of-function experiments in murine embryos.

By microinjecting targeted miR-375-3p inhibitors into early cleavage-stage mouse embryos, the researchers observed a statistically significant reduction in the rate of 8-cell embryo formation (P = 0.0358).

The mouse experiment supports a role for miR-375-3p during the four- to eight-cell transition. It does not establish why every RNA molecule appears in culture medium or prove human clinical selection benefit. Major embryonic genome activation also occurs at different stages in mice and humans, so the mouse transition should not be equated with the human maternal-to-zygotic transition.

Why this biomarker cannot replace PGT-A

Extrapolating these findings to suggest that clinicians can immediately discard embryo biopsies in favor of a single drop of culture fluid would be premature:

Cohort Size and Design: The study analyzed a single-center cohort of 67 grade 1 eight-cell embryos (all morphologically top-grade Grade 1 cleavage embryos from single-embryo transfers: 34 resulting in live birth, 33 in non-birth). Whether these findings hold across lower-grade embryos, Day-5/6 blastocysts, older maternal demographics, or diverse clinical etiologies remains unproven.
Distinct Biological Questions: PGT-A specifically evaluates whole-chromosome numerical copy numbers (aneuploidy). Exosomal miRNA analysis assesses candidate RNA markers associated with live-birth outcome. An embryo can be chromosomally euploid yet lack the metabolic vigor to sustain development, or conversely, an aneuploid embryo might transiently secrete normal levels of regulatory miRNAs. Therefore, SCM testing cannot simply substitute for genetic ploidy testing.
Background Contamination: Culture-medium supplements can complicate extracellular-vesicle analysis. A separate human embryo study detected vesicles in serum-substitute-supplemented controls but not its human-serum-albumin controls, illustrating why appropriate medium-only controls matter.

Rather than replacing PGT-A, exosomal miRNA profiling is being investigated as a possible complement to embryo assessment. Whether using it to choose between similar-looking embryos actually improves live birth requires prospective clinical validation.

What validation is needed before clinical embryo selection?

Embryo assessment in reproductive medicine continues to evolve. What began decades ago as a simple static look through a microscope has advanced through continuous time-lapse monitoring and molecular genetic testing.

This study outlines the next phase of that progression: decoding the active communication signals an embryo releases into its immediate surroundings.

Larger prospective multicenter studies are needed to determine whether these candidate signals improve embryo selection. The present study links a culture-medium marker with live birth in a selected cohort; it does not establish a comprehensive molecular record of an individual embryo’s developmental health.